Hereditary Nonpolyposis Colon Cancer
7
1
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
PeLear CCC: Proyecto Latino Contra Cancer Colorrectal
Smart Measurement of Circulating Tumor DNA
DNA Adductomics for Colorectal Cancer Investigation
Genetic Risk: Whether, When, and How to Tell Adolescents
Collecting Information From Patients and Family Members With Hereditary Colorectal Cancer Syndromes or Who Are at High Risk of Developing Colorectal Cancer
Psychosocial Aspects of Genetic Testing for Hereditary Nonpolyposis Colon Cancer
Educational CD-ROM Compared With Standard Informed Consent for Patients With Colorectal Cancer or a Family History of Colorectal Cancer